Follow
JL Boormans
JL Boormans
Urologist, Erasmus MC, Rotterdam
Verified email at erasmusmc.nl
Title
Cited by
Cited by
Year
Impact of molecular subtypes in muscle-invasive bladder cancer on predicting response and survival after neoadjuvant chemotherapy
R Seiler, HAD Ashab, N Erho, BWG van Rhijn, B Winters, J Douglas, ...
European urology 72 (4), 544-554, 2017
7502017
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guerin, and …
RJ Sylvester, MA Brausi, WJ Kirkels, W Hoeltl, FC Da Silva, PH Powell, ...
European urology 57 (5), 766-773, 2010
4622010
Pembrolizumab monotherapy for the treatment of high-risk non-muscle-invasive bladder cancer unresponsive to BCG (KEYNOTE-057): an open-label, single-arm, multicentre, phase 2 study
AV Balar, AM Kamat, GS Kulkarni, EM Uchio, JL Boormans, M Roumiguié, ...
The Lancet Oncology 22 (7), 919-930, 2021
2752021
Association of hypertension drug target genes with blood pressure and hypertension in 86 588 individuals
AD Johnson, C Newton-Cheh, DI Chasman, GB Ehret, T Johnson, L Rose, ...
Hypertension 57 (5), 903-910, 2011
1972011
EAU guidelines on testicular cancer
MP Laguna, G Pizzocaro, O Klepp, F Algaba, L Kisbenedek, O Leiva
European urology 40 (2), 102-110, 2001
1842001
EAU-ESMO Consensus statements on the management of advanced and variant bladder cancer—an international collaborative multistakeholder effort†: under the auspices of the EAU …
JA Witjes, M Babjuk, J Bellmunt, HM Bruins, TM De Reijke, M De Santis, ...
European urology 77 (2), 223-250, 2020
1642020
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice
GJ Van Leenders, JL Boormans, CJ Vissers, AM Hoogland, AA Bressers, ...
Modern Pathology 24 (8), 1128-1138, 2011
1452011
Impact of molecular subtyping and immune infiltration on pathological response and outcome following neoadjuvant pembrolizumab in muscle-invasive bladder cancer
A Necchi, D Raggi, A Gallina, JS Ross, E Farè, P Giannatempo, ...
European urology 77 (6), 701-710, 2020
1392020
Truncated ETV1, fused to novel tissue-specific genes, and full-length ETV1 in prostate cancer
KG Hermans, HA van der Korput, R van Marion, DJ van de Wijngaart, ...
Cancer research 68 (18), 7541-7549, 2008
1342008
Multicenter randomized comparison of xenon and isoflurane on left ventricular function in patients undergoing elective surgery
F Wappler, R Rossaint, J Baumert, J Scholz, PH Tonner, H van Aken, ...
The Journal of the American Society of Anesthesiologists 106 (3), 463-471, 2007
1302007
Keynote 057: Phase II trial of Pembrolizumab (pembro) for patients (pts) with high-risk (HR) nonmuscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guérin …
AV Balar, GS Kulkarni, EM Uchio, J Boormans, L Mourey, LEM Krieger, ...
Journal of Clinical Oncology 37 (7_suppl), 350-350, 2019
1272019
Validation of a DNA methylation-mutation urine assay to select patients with hematuria for cystoscopy
KEM van Kessel, W Beukers, I Lurkin, A Ziel-van der Made, ...
The Journal of urology 197 (3 Part 1), 590-595, 2017
1252017
Systematic review of immune checkpoint inhibition in urological cancers
M Rijnders, R de Wit, JL Boormans, MPJ Lolkema, AAM van der Veldt
European Urology 72 (3), 411-423, 2017
1032017
Overexpression of prostate-specific TMPRSS2 (exon 0)-ERG fusion transcripts corresponds with favorable prognosis of prostate cancer
KG Hermans, JL Boormans, D Gasi, GJHL van Leenders, G Jenster, ...
Clinical Cancer Research 15 (20), 6398-6403, 2009
1022009
Testicular tumour size and rete testis invasion as prognostic factors for the risk of relapse of clinical stage I seminoma testis patients under surveillance: a systematic …
JL Boormans, JM de Castro, L Marconi, Y Yuan, MPL Pes, C Bokemeyer, ...
European urology 73 (3), 394-405, 2018
992018
FGFR3, TERT and OTX1 as a Urinary Biomarker Combination for Surveillance of Patients with Bladder Cancer in a Large Prospective Multicenter Study
W Beukers, KA van der Keur, R Kandimalla, Y Vergouwe, EW Steyerberg, ...
The Journal of urology 197 (6), 1410-1418, 2017
982017
ETS fusion genes in prostate cancer
DG Tandefelt, J Boormans, K Hermans, J Trapman
Endocrine-related cancer 21 (3), R143-R152, 2014
982014
Treatment of high-grade non–muscle-invasive bladder carcinoma by standard number and dose of BCG instillations versus reduced number and standard dose of BCG instillations …
MO Grimm, AG van der Heijden, M Colombel, T Muilwijk, ...
European urology 78 (5), 690-698, 2020
962020
Divergent biological response to neoadjuvant chemotherapy in muscle-invasive bladder cancer
R Seiler, EA Gibb, NQ Wang, HZ Oo, HM Lam, KE Van Kessel, ...
Clinical cancer research 25 (16), 5082-5093, 2019
962019
Molecular markers increase precision of the european association of urology non–muscle-invasive bladder cancer progression risk groups
KEM van Kessel, KA van der Keur, L Dyrskjøt, F Algaba, NYC Welvaart, ...
Clinical Cancer Research 24 (7), 1586-1593, 2018
942018
The system can't perform the operation now. Try again later.
Articles 1–20